Noninitiation of Discharge Medications After Revascularization
| Autor: | Daniel J. Elliott, Zugui Zhang, Dominique Medaglio, Justin Glasgow |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Cardiovascular event
Male medicine.medical_specialty Time Factors medicine.medical_treatment MEDLINE Pharmaceutical Science Pharmacy Revascularization Drug Prescriptions Medication Adherence Percutaneous Coronary Intervention medicine Myocardial Revascularization Humans Coronary Artery Bypass Intensive care medicine Aged Retrospective Studies Patient discharge business.industry Health Policy Retrospective cohort study Length of Stay Patient Discharge Female business Discharge medications |
| Zdroj: | Journal of managed carespecialty pharmacy. 26(3) |
| ISSN: | 2376-1032 |
| Popis: | Timely initiation of medication therapy after a cardiovascular event is vital to achieve optimal patient outcomes, yet there is a lack of insight on the frequency and predictors of discharge medications that are delayed or never initiated.To (a) describe how frequently patients do not fill newly prescribed discharge medications within 30 days after revascularization and (b) identify predictors of patients who did not fill their new medications.A single-center, retrospective analysis was conducted of patients discharged after percutaneous coronary intervention or coronary artery bypass grafting. Discharge prescriptions were linked to pharmacy claims data to identify medications that were not filled within 30 days of discharge.1,206 patients and their 5,253 discharge medications were included for study. More than one third of patients did not fill at least 1 discharge medication within 30 days (466/1,206, 38.6%); nearly 1 in 10 (116/1,206, 9.6%) did not fill any of their discharge prescriptions. Significant predictors of nonadherence included longer length of stay and higher number of prescribed discharge medications (bothNoninitiation is a common issue among patients after cardiac revascularization. These patients may be at a higher risk of not filling their medications if they experience longer lengths of stay or are prescribed a higher number of medications at discharge.This work was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number U54-GM104941 (PI: Binder-Macleod). The sponsor had no connection with Surescripts and no role in the study design, data analysis, interpretation of results, or development of this manuscript. Glasgow reports personal fees from Burroughs Group, outside the submitted work. The other authors have nothing to disclose. Preliminary results from this work were presented as a poster presentation at the 2018 AcademyHealth Annual Research Meeting; June 24-26, 2018; Seattle, WA. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|